These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15185895)

  • 21. Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING).
    Pipilis A; Farmakis D; Kaliambakos S; Antoniou A; Goudevenos J; Lekakis J;
    Int J Cardiol; 2014 Aug; 175(3):569-70. PubMed ID: 24874899
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Atrial fibrillation in dialysis patients].
    Vázquez Ruiz de Castroviejo E; Sánchez Perales MC
    Nefrologia; 2006; 26(1):16-24. PubMed ID: 16649422
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardioversion of atrial fibrillation for maintenance of sinus rhythm: a road to nowhere.
    Wyse DG; Anter E; Callans DJ
    Circulation; 2009 Oct; 120(14):1444-52. PubMed ID: 19805661
    [No Abstract]   [Full Text] [Related]  

  • 25. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.
    Wyse DG
    Circulation; 2007 May; 115(21):2684-6. PubMed ID: 17533193
    [No Abstract]   [Full Text] [Related]  

  • 26. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticoagulation trials.
    Grahame-Clarke C; Swanton RH
    Br J Hosp Med; 1996 Jun 19-Jul 9; 56(1):25-8. PubMed ID: 8831009
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboembolism in heart failure: who should be treated?
    Diet F; Erdmann E
    Eur J Heart Fail; 2000 Dec; 2(4):355-63. PubMed ID: 11113711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?
    Guthmann RA
    Am Fam Physician; 2004 Sep; 70(5):917-8. PubMed ID: 15368730
    [No Abstract]   [Full Text] [Related]  

  • 33. Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation.
    Ramondo A; Maiolino G; Napodano M; Isabella G; Tarantini G; Bonato R; Pengo V; Ponchia A; Iliceto S
    Ital Heart J; 2005 May; 6(5):414-7. PubMed ID: 15934416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
    Falk RH
    J Am Coll Cardiol; 2004 Oct; 44(8):1567-9. PubMed ID: 15489086
    [No Abstract]   [Full Text] [Related]  

  • 35. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 36. Atrial fibrillation and anticoagulant therapy.
    Wheeldon NM
    Eur Heart J; 1995 Mar; 16(3):302-12. PubMed ID: 7789371
    [No Abstract]   [Full Text] [Related]  

  • 37. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
    Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
    Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 40. [The clinical challenge of the atrial fibrillation].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.